Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
If you're curious about how these medications might fit into your health journey, or if you're already taking them and seeking nutritional support, book an appointment with our team today
In 2012, Hoffman et al
As noted within an article appearing on CNBC, "Novo Nordisk's new Wegovy GLP-1 pill appears to be expanding the obesity treatment market, drawing in new patients rather than converting existing ones from injections." If this proves to be a sustainable trend, then a successful GLP-1 pill sector could power the broader GLP-1 market to become even larger than original projections and provide enhanced opportunities for Lexaria's DehydraTECH
Eligibility and Supervised Use Saxenda is particularly recommended for individuals with a Body Mass Index (BMI) exceeding 30 kg/m, or for those with a BMI over 27 kg/m accompanied by chronic conditions such as hypertension, type 2 diabetes, or hyperlipidemia
Most side effects are temporary, but its always better to be safe
US$ 25.26
US$ 26.53
US$ 29.90
US$ 24.91
